Wedbush Securities’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8
Closed -$4K 1083
2022
Q3
$4K Hold
8
﹤0.01% 1040
2022
Q2
$6K Hold
8
﹤0.01% 1062
2022
Q1
$29K Sell
8
-4
-33% -$10.5K ﹤0.01% 1086
2021
Q4
$35K Sell
12
-1
-8% -$4.64K ﹤0.01% 1161
2021
Q3
$82K Sell
13
-9
-41% -$77.7K ﹤0.01% 1142
2021
Q2
$291K Hold
22
0.01% 880
2021
Q1
$370K Buy
22
+13
+144% +$254K 0.02% 707
2020
Q4
$153K Sell
9
-61
-87% -$1.15M 0.01% 808
2020
Q3
$1.31M Buy
70
+27
+63% +$621K 0.13% 170
2020
Q2
$1.13M Sell
43
-3
-7% -$85K 0.11% 198
2020
Q1
$1M Sell
46
-17
-27% -$272K 0.12% 176
2019
Q4
$578K Buy
63
+27
+75% +$261K 0.05% 411
2019
Q3
$340K Buy
36
+22
+157% +$268K 0.03% 588
2019
Q2
$216K Sell
14
-33
-70% -$547K 0.02% 786
2019
Q1
$969K Sell
47
-1
-2% -$17.8K 0.1% 230
2018
Q4
$589K Buy
48
+2
+4% +$34.7K 0.08% 305
2018
Q3
$1.14M Buy
46
+23
+100% +$701K 0.13% 184
2018
Q2
$775K Buy
23
+11
+92% +$422K 0.1% 242
2018
Q1
$492K Buy
12
+1
+9% +$38K 0.06% 367
2017
Q4
$519K Buy
+11
New +$515K 0.06% 375

Other funds holding KALA

Wedbush Securities's KALA Position: Q4 2022 in Review

Wedbush Securities sold out of KALA BIO (KALA) in Q4 2022, closing a stake of 8 shares — an estimated $4K sold.

Wedbush Securities first reported a position in KALA in Q4 2017 and held it in 20 quarters. The position peaked at $1.31M in Q3 2020. 28 funds tracked by Wall St. Rank hold KALA as of Q4 2022.

  • Wedbush Securities reported no remaining KALA BIO position as of Q4 2022 after selling out during the quarter.
  • Wedbush Securities sold 8 KALA BIO shares in Q4 2022, an estimated $4K.
  • Wedbush Securities first reported a position in KALA BIO in Q4 2017 and held it in 20 quarters.
  • Wedbush Securities's KALA BIO position peaked at $1.31M in Q3 2020.
  • 28 funds tracked by Wall St. Rank held KALA BIO as of Q4 2022.

Based on Wedbush Securities's 13F filing for Q4 2022, filed 31 Jan 2023.